Neuronal voltage-gated potassium channel (Kv channel) (Kv channel)

Neuronal voltage-gated potassium channels (Kv channels) are essential transmembrane proteins that regulate the flow of potassium ions across the neuronal membrane in response to changes in electrical potential [Gutman GA, et al., 2005]. These channels are fundamental to the nervous system, as they facilitate the repolarization phase of action potentials, set the resting membrane potential, and determine the firing frequency of neurons [StatPearls, 2023]. By modulating the duration and shape of electrical impulses, Kv channels directly influence neurotransmitter release and synaptic plasticity [Wulff H, et al., 2009]. Mutations in the genes encoding these channels, such as KCNQ2 or KCNA1, are associated with various channelopathies including neonatal epilepsy and episodic ataxia [Cooper EC, 2012]. Therapeutically, Kv channel openers like retigabine are used to treat seizures by stabilizing the resting potential, while blockers like dalfampridine are used in multiple sclerosis to improve walking by enhancing conduction in demyelinated nerves [Judge SI, 2006]. Their diverse subtypes and localized expression patterns make them highly specific targets for treating chronic pain, cognitive deficits, and movement disorders [Wickenden AD, 2002].

Other names

Voltage-gated potassium channelVoltage-dependent potassium channelKv channelK+ channel

Drugs targeting these channels typically act as either positive allosteric modulators (openers) to stabilize the membrane potential and reduce neuronal firing, or as channel blockers to prolong action potential duration and enhance synaptic transmission in compromised neurons.